Neuroscience at HIH Home
NINDS Home NIMH Home NICHD Home NIDCD Home NEI Home NIDCR Home NIA Home NIAAA Home NIDA Home NHGRI Home NIEHS Home NCI Home
National Institutes of Health - Neuroscience at HIH Link to NIH
Link to About Us
Link to Faculty
Link to Areas of Research
Link to Seminars
Link to Interest Groups
Link to Post-doctoral Openings
Link to Home
 

Esther M. Sternberg, M.D., Senior Investigator

Dr. Sternberg received her M.D. degree in 1974 from McGill University, Montreal, Canada. She obtained her clinical training in Rheumatology from Royal Victoria Hospital and McGill University. Dr. Sternberg completed postdoctoral training within the Division of Allergy and Immunology at Washington University, Barnes Hospital, St. Louis, MO. She was subsequently an Associate of the Howard Hughes Medical Institute and Instructor in Medicine at Washington University and Barnes Hospital. Dr. Sternberg moved to the NIMH in 1986 and is currently a Senior Investigator and chief of the Section on Neuroendocrine Immunology and Behavior. For much of her career she has investigated the interaction between the central nervous system and the immune system. Dr. Sternberg's work has helped to define the role of the brain's stress response in susceptibility to rheumatoid arthritis and other inflammatory diseases, and has shed light on the underlying mechanisms for the connection between stress, depression and autoimmune disease.
Photo of Esther   M. Sternberg, M.D., Senior Investigator

Staff:



Research Interests:
The mission of the SNIB is to advance the understanding of the role of neuroendocrine and neural factors in susceptibility and resistance to immune mediated disorders, including autoimmune, inflammatory and infectious disorders. These studies are carried out at a molecular level (glucocorticoid, estrogen and other nuclear hormone receptors; cytokine and cytokine receptors); cellular level (immune/inflammatory responses; hypothalamic cell neurohormone and neuropeptide production); neuroanatomical level (neurohormone and immune molecule mRNA and peptide expression in brain); systems level (neuroendocrine, immune and physiological responses). While previous studies primarily focused on neural and hypothalamic mechanisms in susceptibility and resistance to inflammatory disease in rat models, current studies focus on bacterial toxin repression of the glucocorticoid receptor, and the role of this effect in inflammation and shock. This focus stems from the SNIB�s recent discovery that B. anthracis lethal toxin selectively represses the glucocorticoid and other nuclear hormone receptors (J.I. Webster et al., PNAS, 2003). These studies have important implications for understanding the pathophysiology and treatment of bacterial shock, and the role of host factors in susceptibility and resistance to infectious and pro-inflammatory agents.

The clinical research program of the SNIB focuses on developing quantitative measures for stress and immune biomarkers in ambulatory settings.


Contact Information:

Dr. Esther M. Sternberg
Neuroendocrine Immunology and Behavior Section
Clinical Neuroendocrinology Branch, NIMH
Building 10, Room 2D46
10 Center Drive, MSC 1284
Bethesda, MD 20892-1284

Telephone: (301) 402-2773 (office), (301) 496-1891 (laboratory), (301) 402-1561 (fax)
Email: sternbee@mail.nih.gov

top

Home   |   Email List   |   Search   |   Contact Us   |   Privacy Notice   |   Disclaimer   |   Accessibility
Comments or questions about the website?
Send email to neuroscience@nih.gov
Last updated Thursday, September 08, 2005